IDPH--Positive preliminary results for pivotal trial of ID Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: guido leone who wrote (1548)	4/24/1998 12:56:00 AM
From: Howard Hoffman	Read Replies (2) of 1762

Guido, Hi. Long time no see. Basically, I think that the stock was riding high until sales figures from Genentech and earnings from IDPH showed that IDEC "only" has a $120M/yr or so drug so far. The stock fell to the "one drug" price. Considering the pipeline, I believe IDPH is currently undervalued. A lot of people had a very low basis on this stock and took profits. Longer term, be patient and this great co. will reward us, I believe. I am thinking of flying down to San Diego for the annual meeting. Anyone else going? Regards, Howard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next